What Mounjaro weight loss does to your face

Facial fat loss during weight loss on Mounjaro is a physiological response to reduced overall body fat — the medicine does not target the face specifically.
The degree of change depends on how much weight is lost, your starting body composition, age, and skin elasticity.
Skin laxity can become more visible as fat volume decreases; this is more pronounced with rapid or large weight reductions.
Staying well hydrated, maintaining adequate protein intake, and discussing any concerns with your prescriber can all support skin quality during treatment.

When people lose a significant amount of weight on Mounjaro, changes to the face are common and noticeable — sometimes more so than changes elsewhere on the body. Fat redistributes, skin loses some of its previous volume, and features can look sharper or more defined than before. This is a normal part of substantial weight loss, not a side effect of tirzepatide itself, and knowing what to expect helps you make an informed decision. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses whether it is clinically suitable for you before any treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How facial changes unfold during Mounjaro treatment, and what the evidence says

Step 1: Understanding why the face changes as weight comes off

The face holds a meaningful proportion of subcutaneous fat, distributed across the cheeks, temples, jaw and under the chin. When the body enters a sustained calorie deficit (which Mounjaro supports by reducing appetite through its dual GIP and GLP-1 receptor activity) it draws on fat stores throughout the body, and the face is no exception.

This process is not unique to tirzepatide. It happens with any approach that produces significant weight loss. What makes it more noticeable with Mounjaro is the scale of loss that the medicine can support: in the SURMOUNT-1 trial, participants lost an average of around 20–21% of body weight at the 15mg dose over 72 weeks, as published in the New England Journal of Medicine. At that level of loss, facial changes are almost inevitable for most people.

The rate of loss matters too. A faster reduction tends to leave less time for skin to adapt, which can make hollowing or looseness around the cheeks and jaw more apparent. Slower, steadier loss gives skin a better chance to contract gradually, one reason prescribers titrate the dose carefully rather than starting at the highest strength.

Step 2: Recognising what 'Mounjaro face' actually looks like

The phrase "Mounjaro face" has become shorthand for the facial changes that can accompany significant GLP-1-assisted weight loss. In practice, people describe a few distinct patterns.

The most common is a reduction in cheek fullness, which can make the cheekbones and orbital bones around the eyes more prominent. Some people notice their jaw looks more defined. Others find that hollowing appears under the eyes or at the temples, where fat pads are naturally thin to begin with. For some this is a welcome part of feeling healthier; for others it feels more pronounced than expected.

Skin laxity (where skin appears looser or slightly crepey) can also develop, particularly in people over 40 or those who lose a large amount of weight quickly. Collagen and elastin in the skin need time to remodel, and fat volume helps give the face its structure. When that volume reduces faster than the skin can adapt, some sagging at the jowls or neck can appear. The NHS patient information on tirzepatide does not list facial changes as a direct side effect because they are not caused by the medicine pharmacologically, they are caused by the weight loss itself.

None of this means the outcome is negative. Many people report that their face looks healthier, their neck is less full, and they feel more recognisable to themselves. The experience varies considerably from person to person.

Step 3: Practical steps to support your face during treatment

There is no way to tell the body to lose fat from one area and spare another. But there are practical approaches that can improve how skin adapts during treatment.

Protein intake is probably the most important nutritional factor. Adequate dietary protein supports collagen synthesis and helps preserve lean muscle mass, which in turn supports skin structure. Prescribers often encourage patients to prioritise protein, particularly as appetite falls and total food intake reduces. A rough target of 1.2–1.6g of protein per kilogram of body weight per day is commonly discussed, though your prescriber or a dietitian should advise the right level for you personally.

Hydration matters. Well-hydrated skin maintains turgor more effectively, and tirzepatide's gastrointestinal effects (particularly nausea in the early weeks) can reduce fluid intake if patients are not careful. Sipping water consistently through the day is straightforward advice that makes a real difference.

Strength-based exercise helps preserve muscle as fat reduces, which has a modest but real effect on how the face retains structure. And gradual dose titration, rather than accelerating increases, gives skin more time to adapt, something a prescriber at a service like ours builds into the treatment plan from the start. If you are thinking about the cost side of things, our Mounjaro cost guide sets out what private treatment actually includes.

Step 4: When to mention facial changes to your prescriber

Facial changes during weight loss do not usually require clinical intervention, but there are moments when raising them with your prescriber is worthwhile. If the rate of weight loss feels very fast and facial changes are distressing, your prescriber can review whether the current dose is appropriate for you. If skin changes are significant and you are considering cosmetic treatments to address them, telling the clinical team matters, some injectable aesthetic procedures interact with treatment in ways worth discussing beforehand.

Our prescribers review every patient's progress before each repeat order; it is not a one-off consultation followed by automated dispatches. The same clinician who approved your treatment can hear your concerns about how your face is changing and adjust the plan if needed. That ongoing relationship is, frankly, one of the most important things a regulated service offers, and one of the things that gets overlooked when people focus only on price.

For a broader picture of how tirzepatide works and what the treatment journey looks like, the Mounjaro weight loss overview covers the full clinical picture. If you are specifically curious about the physical changes to facial appearance in more detail, our dedicated Mounjaro face page goes deeper. And for everything about tirzepatide as a medicine, including how the dual-agonist mechanism differs from older GLP-1 treatments, the tirzepatide overview is a good starting point.

When you are ready to find out whether Mounjaro is clinically suitable for you, our prescribers are available the same day. If you would like to understand how Mounjaro affects weight across different stages of treatment, that detail is covered in full on the relevant page. Your consultation arrives on a real clinician's desk, not an automated queue. Once approved, your pen is dispatched the same day if you order before 12pm, tracked by DPD, in a plain unbranded box, arriving the next working day. Speak to our prescribers to get started, or if you want to explore the weight loss jab Mounjaro in more detail before you do, that page walks through how the injection works and what to expect.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions